Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.

An engineered E. coli strain survived after one amino acid was designed out of many of its ribosomal proteins—an early test ...

Years before he conducted the research that would earn him a Nobel Prize in Physiology and Medicine, Shinya Yamanaka, MD, ...

Scientists shared transcripts with The Times in which chatbots described how to assemble deadly pathogens and unleash them in ...

Researchers use AI to discover 14 distinct nucleosome states, revealing that DNA packaging acts as a "volume dial" for gene ...

Scientists at Lund University used exosomes from flatworms to accelerate human skin repair. This builds on the discovery of ...

AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...

For most of us, pain is an unwelcome but vital warning system that tells us when something is wrong. However, for the small ...

The field of infectious disease research faces persistent challenges in bridging the gap between laboratory findings and successful clinical translation.

Researchers at Baylor College of Medicine and collaborating institutions developed a method that reveals the cellular makeup ...

Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...